Concepedia

Phil Bergman

PB

9

Publications

512

Citations

9

H-Index

2004

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Novartis Institutes for BioMedical Research

Harvard University

Massachusetts General Hospital

Phil Bergman is an author at Novartis (Switzerland) specializing in medicine, cell biology, and gene expression.

Top concepts

Publications per year

2004–2025

9

Publications

9

<scp>TMEM</scp> 41B is a novel regulator of autophagy and lipid mobilization

Francesca Moretti, Phil Bergman, Stacie E. Dodgson et al. · EMBO Reports · 2018 · 171 citations · Full text

, , +9

Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62

Rowena DeJesus, Francesca Moretti, Gregory McAllister et al. · eLife · 2016 · 152 citations · Full text

, , +16

TFEB Transcriptional Responses Reveal Negative Feedback by BHLHE40 and BHLHE41

Kimberly L. Carey, Geraldine L. C. Paulus, Lingfei Wang et al. · Cell Reports · 2020 · 54 citations · Full text

, , +18

Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma

Heather L. Gardner, Cheryl A. London, Roberta A. Portela et al. · BMC Veterinary Research · 2015 · 47 citations · Full text

Incidence of type 1 diabetes in 0 to 14 year olds in Australia from 2002 to 2017

Aveni Haynes, Max Bulsara, Phil Bergman et al. · Pediatric Diabetes · 2020 · 31 citations · Full text

Rows per page

1–5 of 9